MIPM - Successful introduction of worker management and further training

San Francisco, 02.12.2024 - MIPM Mammendorfer Institut für Physik und Medizin GmbH (MIPM) is pleased to announce a significant advance in medical technology. Head of Development Andreas Klement and Development Engineer David Huppertz have successfully completed a desaturation study with an innovative oxygen saturation sensor at the renowned University of San Francisco.

In this comprehensive study, the precision of the new sensor was thoroughly tested when measuring different oxygen saturations in the blood of patients. The results confirm the high accuracy and reliability of the sensor, even under varying conditions.

‘This study marks an important milestone for MIPM's future products,’ explains Andreas Klement. ‘The new sensor will not only significantly improve the quality of our medical devices, but also ensure our company's independence in development and production.’

David Huppertz adds: ‘We are proud that our research and development has led to such ground-breaking results. This is a major step forward for medical technology and will have a positive impact on patient care worldwide.’

MIPM continues to focus on innovation and quality to revolutionise healthcare and provide patients with the best possible care.